Anne Klibanski, M.D.

President and CEO, Mass General Brigham; Laurie Carrol Guthart Professor of Medicine, Harvard Medical School

Anne Klibanski, M.D. is the President and Chief Executive Officer of Mass General Brigham, a Boston-based integrated health care system that includes internationally known Brigham and Women’s Hospital and Massachusetts General Hospital, nationally recognized specialty hospitals including Spaulding, Mass Eye and Ear, and McLean, seven community hospitals, a health insurance company, physician networks, community health centers, home care and long-term care services. The largest private employer in Massachusetts with 78,000 employees and annual revenue of $13.4 billion, the non-profit health care system is the nation’s leading recipient of NIH funding and a principal teaching affiliate of Harvard Medical School, establishing the health care system’s position as a national leader in medical research and teaching.

Appointed to her role as President and CEO in June 2019, Dr. Klibanski’s vision for Mass General Brigham is to build the integrated academic health care system of the future with patients at the center, transforming care, improving outcomes and expanding impact locally, nationally and globally.

Dr. Klibanski has served as the health care system’s Chief Academic Officer and as Chief of Neuroendocrine at Massachusetts General Hospital. She is recognized internationally for her high impact research in neuroendocrine disorders and pituitary tumors.  Dr. Klibanski received her B.A., magna cum laude in literature from Barnard College and her M.D. from New York University Medical Center. She is the Laurie Carrol Guthart Professor of Medicine at Harvard Medical School. 

Team members

David Chiswell, Ph.D. – Chairman

Former CEO, Cambridge Antibody Technology (CAT), Nabriva Therapeutics and Kymab; Currently Chairman, Epsilogen and Board Member of Avillion Bond 2 Development 2 GP

Anne Klibanski, M.D.

President and CEO, Mass General Brigham; Laurie Carrol Guthart Professor of Medicine, Harvard Medical School

Michael Gutch, Ph.D.

Chief Business Officer and Chief Financial Officer, Entasis Therapeutics

Roger A. Jeffs, Ph.D.

Former President and co-CEO, United Therapeutics

Stephanie S. Okey, M.S.

Former Senior Vice President, Head of North America, Rare Diseases, Genzyme, a Sanofi Company

Davey S. Scoon

Former CFO, Tom’s of Maine; Board of Trustees, Allianz Global Investors

Ron Cooper

President and Chief Executive Officer